Bio Nicsgene Co.,Ltd. announced that it has received KRW 19.99999291 billion in funding from BIOVILL Co.,Ltd., Hanryu Bank Co., Ltd., and another investor
December 19, 2018
Share
On December 20, 2018, Bio Nicsgene Co.,Ltd. (KOSDAQ:A222810) closed the transaction.
Setopia Co Ltd, formerly Midas AI Co Ltd, is a Korea-based company mainly engaged in the development and supply of information security solutions. The Company operates its business through two segments. The Security Business segment is mainly engaged in the development and sale of data loss prevention (DLP) solutions, security universal serial buses (USBs) management solutions, privacy solutions and others. The Service Business segment is engaged in the provision of system integration (SI) and system management (SM) related services. In addition, the Company is engaged in the export business include coronavirus disease (COVID)-19 diagnostics, diagnostic kits, personal blood glucose meters, blood glucose meters used in measuring devices and others.
Bio Nicsgene Co.,Ltd. announced that it has received KRW 19.99999291 billion in funding from BIOVILL Co.,Ltd., Hanryu Bank Co., Ltd., and another investor
SETOPIA CO.,LTD. 
